<DOC>
	<DOCNO>NCT01326572</DOCNO>
	<brief_summary>HIV-infected patient increase incidence emphysema compare non-HIV-infected patient , hypothesize accelerated disease progression result one latent infection amplifies pulmonary inflammatory response . The investigator examine prevalence progression emphysema subject without HIV determine risk factor emphysema population .</brief_summary>
	<brief_title>Lung HIV Disease Large Cohort-Pitt</brief_title>
	<detailed_description>Specific Aim 1 : To test hypothesis emphysema prevalent progress quickly HIV+ subject compare HIV- control : The investigator characterize prevalence , nature , progression HIV-associated emphysema . Emphysema determine HIV+ HIV- subject spirometry , diffuse capacity , quantitative compute tomography and/or EBCT . These study repeat 18 36 month baseline assess difference progression HIV+ HIV- subject . Multifactorial regression analysis determine contribution various risk factor presence progression emphysema . The investigator perform pulmonary function test baseline compare degree obstruction accord HIV status adjust clinical variable influence lung function . Assessment degree emphysema distribution accomplish use quantitative CT morphometry density analysis . This technique measure lung density pixel analysis express Hounsfield unit ( HU ) inverse ( ml gas/gram tissue ) increase proportionately magnitude emphysema . These measurement histologically-verified give quantitative , reproducible measurement percentage distribution lung consider normal , mildly emphysematous , severely emphysematous . The investigator compare emphysema HIV+ HIV- subject compare progression time . Specific Aim 2 : To establish bank saliva , sputum , serum , plasma , DNA , RNA , proteins cell biological sample subject purpose perform future proteomic genomic analysis gene expression , genetic association , disease pathogenesis marker disease progression subject HIV infection lung disease : 2a ) To test role low level infection physiologic obstruction HIV-infected patient . The investigator examine role co-infection Pneumocystis microbes pathogenesis HIV-associated emphysema mechanism cause emphysema progression examine induced sputum specimen baseline , 18 month , 36 month . Specific Aim 3 . To test hypothesis persistent , sub-clinical infection HIV+ subject augments pulmonary inflammatory response lead emphysema . 3a . To test hypothesis pulmonary colonization increase subject HIV-associated emphysema . The investigator perform serial bronchoscopic alveolar lavage ( BAL ) four group HIV+ HIV - subject : smoker emphysema , smoker without emphysema , non-smokers emphysema , non-smokers without emphysema four sub-study site . The investigator use culture molecular technique test pathogen associate emphysema and/or HIV compare result group baseline time test hypothesis HIV+ subject emphysema harbor sub-clinical infection infection accelerate lung damage inflammation . The investigator also determine pulmonary HIV level relationship emphysema colonization . 3b . To test hypothesis local inflammatory response protease upregulated HIV+ subject emphysema . BAL cellular infiltration characterize flow cytometry develop quantitative qualitative evaluation cellular inflammatory response four patient group Aim 3a . Lymphocyte population analyze activation marker intra-cellular cytokine production . The investigator measure cytokine expression protease level BAL supernatant well macrophage protease production . The investigator compare result group correlate infection HIV BAL viral level .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Age 18 year old old By participant 's report , s/he : HIV positive OR HIV negative high risk Recruited via : Pitt Men 's Study/MAC Women 's Interagency Health Study Attendee UPMC HIV/AIDS Program Acute onset shortness breath , cough , fever heart condition tachycardia , angina arrhythmias Pregnancy MI , CVA cardiovascular event within last 3 month Eye abdominal surgery last 3 month Active TB documentation selfreport Weight &gt; 500 lb . Exposure &gt; 10 rad previous 12 month ( i.e. , 2 CT 4 cardiac cathâ€¦or fluoroscopic exam For bronchoscopy subject Subjects upper low respiratory tract infection Individuals Primary diagnosis vocal cord dysfunction , significant uncontrolled systemic disease exclude 75 year age old</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Pulmonary disease</keyword>
	<keyword>emphysema</keyword>
	<keyword>COPD</keyword>
</DOC>